BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wimmer E, Ihrler S, Gires O, Streit S, Issing W, Bergmann C. Fibroblast growth factor receptor 4 single nucleotide polymorphism Gly388Arg in head and neck carcinomas. World J Clin Oncol 2019; 10(3): 136-148 [PMID: 30949443 DOI: 10.5306/wjco.v10.i3.136]
URL: https://www.wjgnet.com/1948-5182/full/v10/i3/136.htm
Number Citing Articles
1
Tao Peng, Yangyang Sun, Zhiwei Lv, Ze Zhang, Quanxin Su, Hao Wu, Wei Zhang, Wei Yuan, Li Zuo, Li Shi, Li-Feng Zhang, Xiaoli Zhou, Yuanyuan Mi. Effects of FGFR4 G388R, V10I polymorphisms on the likelihood of cancerScientific Reports 2021; 11(1) doi: 10.1038/s41598-020-80146-y
2
Ju-Pi Li, Hsien-Cheng Huang, Po-Jen Yang, Chien-Yuan Chang, Yu-Hua Chao, Thomas Chang-Yao Tsao, Hsuan Huang, Yu-Ching Hung, Ming-Ju Hsieh, Shun-Fa Yang. FGFR4 Gene Polymorphism Reduces the Risk of Distant Metastasis in Lung Adenocarcinoma in TaiwanInternational Journal of Environmental Research and Public Health 2020; 17(16): 5694 doi: 10.3390/ijerph17165694
3
Jung Han Kim, Soo Young Jeong, Hyun Joo Jang, Sung Taek Park, Hyeong Su Kim. FGFR4 Gly388Arg Polymorphism Reveals a Poor Prognosis, Especially in Asian Cancer Patients: A Meta-AnalysisFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.762528
4
Abdolkarim Moazeni-Roodi, Sahel Sarabandi, Shima Karami, Mohammad Hashemi, Saeid Ghavami. An updated meta-analysis of the association between fibroblast growth factor receptor 4 polymorphisms and susceptibility to cancerBioscience Reports 2020; 40(10) doi: 10.1042/BSR20192051